SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare informs about analyst meet

15 Sep 2022 Evaluate

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’) read with part A of Schedule III of the Listing Regulations, Themis Medicare has informed that the management of the Company will do an online meeting with Analysts/Investors on Tuesday, 20th September 2022; the details of the same are enclosed. The schedule of the aforesaid meetings is subject to change and changes may happen due to exigencies on the part of Fund / Broking House / Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company: www.themismedicare.com.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

90.00 -0.25 (-0.28%)
20-Apr-2026 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1237.15
Cipla 1237.65
Zydus Lifesciences 941.70
Lupin 2324.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×